nodes	percent_of_prediction	percent_of_DWPC	metapath
Bacitracin—A2M—mammary gland—sarcoma	0.0644	0.084	CbGeAlD
Bacitracin—IDE—hematopoietic system—sarcoma	0.0509	0.0664	CbGeAlD
Bacitracin—A2M—myometrium—sarcoma	0.0457	0.0596	CbGeAlD
Bacitracin—A2M—embryo—sarcoma	0.0439	0.0573	CbGeAlD
Bacitracin—A2M—seminal vesicle—sarcoma	0.0413	0.0538	CbGeAlD
Bacitracin—A2M—hematopoietic system—sarcoma	0.0392	0.0511	CbGeAlD
Bacitracin—IDE—uterus—sarcoma	0.0385	0.0502	CbGeAlD
Bacitracin—A2M—connective tissue—sarcoma	0.0378	0.0492	CbGeAlD
Bacitracin—A2M—smooth muscle tissue—sarcoma	0.0345	0.0451	CbGeAlD
Bacitracin—A2M—skin of body—sarcoma	0.0341	0.0445	CbGeAlD
Bacitracin—IDE—tendon—sarcoma	0.0337	0.044	CbGeAlD
Bacitracin—IDE—bone marrow—sarcoma	0.0327	0.0426	CbGeAlD
Bacitracin—A2M—IL6-mediated signaling events—MITF—sarcoma	0.0306	0.131	CbGpPWpGaD
Bacitracin—A2M—cardiac atrium—sarcoma	0.0298	0.0388	CbGeAlD
Bacitracin—A2M—uterus—sarcoma	0.0296	0.0386	CbGeAlD
Bacitracin—IDE—testis—sarcoma	0.0279	0.0364	CbGeAlD
Bacitracin—A2M—lymphoid tissue—sarcoma	0.0276	0.036	CbGeAlD
Bacitracin—IDE—liver—sarcoma	0.0264	0.0344	CbGeAlD
Bacitracin—A2M—tendon—sarcoma	0.026	0.0339	CbGeAlD
Bacitracin—A2M—bone marrow—sarcoma	0.0251	0.0328	CbGeAlD
Bacitracin—A2M—Degradation of the extracellular matrix—COL18A1—sarcoma	0.0235	0.101	CbGpPWpGaD
Bacitracin—A2M—testis—sarcoma	0.0215	0.028	CbGeAlD
Bacitracin—A2M—liver—sarcoma	0.0203	0.0265	CbGeAlD
Bacitracin—IDE—lymph node—sarcoma	0.0202	0.0264	CbGeAlD
Bacitracin—A2M—Platelet degranulation—VEGFC—sarcoma	0.0194	0.0831	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	0.0185	0.0792	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—FOXO1—sarcoma	0.0165	0.0709	CbGpPWpGaD
Bacitracin—A2M—lymph node—sarcoma	0.0156	0.0203	CbGeAlD
Bacitracin—IDE—Alzheimers Disease—TP53—sarcoma	0.0114	0.0489	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—COL18A1—sarcoma	0.00984	0.0422	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—JUN—sarcoma	0.00862	0.037	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.00859	0.0369	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—MYC—sarcoma	0.00693	0.0297	CbGpPWpGaD
Bacitracin—A2M—Degradation of the extracellular matrix—MMP2—sarcoma	0.0067	0.0287	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TEK—sarcoma	0.00604	0.0259	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—ANGPT2—sarcoma	0.00552	0.0237	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—VEGFA—sarcoma	0.00492	0.0211	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	0.00469	0.0201	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—VEGFC—sarcoma	0.00443	0.019	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PLCG1—sarcoma	0.00348	0.0149	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—KDR—sarcoma	0.00344	0.0147	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—MMP2—sarcoma	0.00281	0.012	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—IL2—sarcoma	0.00257	0.011	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—SRC—sarcoma	0.00224	0.00962	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—VEGFA—sarcoma	0.00218	0.00937	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TLE1—sarcoma	0.00178	0.00764	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ENO2—sarcoma	0.00166	0.00713	CbGpPWpGaD
Bacitracin—A2M—Metabolism—HBA1—sarcoma	0.00165	0.00709	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—VEGFC—sarcoma	0.0015	0.00644	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PLCG1—sarcoma	0.00141	0.00605	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—IL2—sarcoma	0.00132	0.00568	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FLT1—sarcoma	0.0012	0.00515	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PLCG1—sarcoma	0.00118	0.00506	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—SRC—sarcoma	0.00116	0.00496	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CXCR4—sarcoma	0.00113	0.00486	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—VEGFA—sarcoma	0.00113	0.00483	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ATF1—sarcoma	0.00112	0.00481	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—NRAS—sarcoma	0.00111	0.00477	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—KRAS—sarcoma	0.000957	0.0041	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IGF1R—sarcoma	0.00088	0.00377	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TP53—sarcoma	0.000851	0.00365	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FOXO1—sarcoma	0.000837	0.00359	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PDGFRB—sarcoma	0.000836	0.00359	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PDGFRA—sarcoma	0.000823	0.00353	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—HRAS—sarcoma	0.000813	0.00349	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—KDR—sarcoma	0.000693	0.00297	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—KIT—sarcoma	0.000638	0.00274	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CREB1—sarcoma	0.000607	0.00261	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MDM2—sarcoma	0.000503	0.00216	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IL2—sarcoma	0.000449	0.00193	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCND1—sarcoma	0.000438	0.00188	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—JUN—sarcoma	0.000437	0.00187	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CTNNB1—sarcoma	0.000433	0.00186	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SRC—sarcoma	0.000392	0.00168	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—VEGFA—sarcoma	0.000382	0.00164	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NRAS—sarcoma	0.000377	0.00162	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MYC—sarcoma	0.000351	0.00151	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—EGFR—sarcoma	0.000343	0.00147	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—KRAS—sarcoma	0.000324	0.00139	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TP53—sarcoma	0.000288	0.00124	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HRAS—sarcoma	0.000276	0.00118	CbGpPWpGaD
